Single-dose oral anti-arrhythmic drugs for cardioversion of recent-onset atrial fibrillation: a systematic review and network meta-analysis of randomized controlled trials.
Omar A IbrahimEmilie P Belley-CôtéKevin J UmAdrian M BaranchukAlexander P BenzShreyash DalmiaChang N WangWaleed AlhazzaniDavid ConenPhilip J DevereauxRichard P WhitlockJeff S HealeyWilliam F McintyrePublished in: Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology (2021)
Single oral dose Class 1C AADs are effective and safe for cardioversion of recent-onset AF. Flecainide may be superior to propafenone. Amiodarone is a slower acting alternative.